Key facts
- It has raised $10.0M; the latest was Early Stage VC ($10.0M) in Jan 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Aiqing Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Aiqing Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aiqing Medical
Manufacturer of medical-grade electrolytic water products designed for clinical care purposes. The company offers sterilization processes, advanced filtration mechanisms, modular design for varied healthcare settings, compliance with regulatory standards, and support for automated operation, enabling hospitals and medical institutions to improve patient safety, reduce contamination risks, streamline operational workflows, enhance reliability in treatment environments, and maintain consistent quality across diverse applications in modern healthcare practice.
- Sector
- Business Products and Services (B2B)
- HQ
- Hangzhou, China
- Founded
- 2024
- Employees
- 59
- Ownership
- Privately Held (backing)
Aiqing Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aiqing Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aiqing Medical in its N-PORT filings yet. We sweep new filings monthly.